FDA Requests Stakeholder Participation in PDUFA Reauthorization Consultation Meetings

Summary

The FDA is seeking public input from patient advocacy groups, healthcare professionals, and scientific experts to ensure consistent representation in periodic consultation meetings on the reauthorization of the Prescription Drug User Fee Act (PDUFA), which expires in September 2017.